Arcalyst

RILONACEPT treats inflammatory conditions, such as cryopyrin-associated perioidic syndromes (CAPS), deficiency of interluekin-1 receptor antagonist (DIRA), and pericarditis. It works by decreasing inflammation. This reduces symptoms.

With the Patient Assistance Program from Kiniksa Pharmaceuticals , eligible patients will receive free medications for up to one year.